Newsfeeds Archive - Page 31 of 107

2 minute read

Red White & Bloom FY22 Revenue Grows 161.6%, Here Is What You Need To Know

May 16, 8:12 AM

Red White & Bloom Brands Inc. (OTCEM:RWBYF) (CSE:RWB) filed its consolidated audited financial statements, revealing revenue of CA$97.5 million ($72.4 million) for fiscal year 2022, an increase of 161.6% compared to CA$37.3 million in fiscal year 2021.

CSE:RWB

2 minute read

Indiva Q1 Revenue Grows 6% YoY, Provides Outlook

By Vuk Zdinjak

May 16, 7:48 AM

Indiva Limited (OTCPK:NDVAF)1 (TSXV:NDVA) released its financial and operating results for the first fiscal quarter ended March 31, 2023, revealing net revenue of CA$9.4 million, ($7 million) representing a 1.1% sequential increase from Q4 2022, and a 6.0% increase year-over-year from Q1 2022.

NDVAF

2 minute read

AYR Wellness Q1 Revenue Grows 18.3% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak

May 16, 7:29 AM

AYR Wellness Inc. (OTCQX: AYRWF) (CSE:AYR.A) released its financial results for the first quarter ended March 31, 2023.

AYRWF

2 minute read

iAnthus Q1 Revenue Declines 14.1% YoY, What About Profit?

By Vuk Zdinjak

May 16, 7:00 AM

iAnthus Capital Holdings, Inc. (OTCPK:ITHUF) (CSE:IAN) released its financial results for the first quarter ended March 31, 2023, revealing revenue of $36.8 million, a sequential decrease of 2.2% from Q4 2022 and a decrease of 14.1% from the same quarter in the prior year.

CSE:IAN

2 minute read

Cara Therapeutics Revenue Grows 29% To $6.2M

By Vuk Zdinjak

May 16, 6:52 AM

Cara Therapeutics, Inc. (NASDAQ: CARA) released its financial results for the first quarter ended March 31, 2023, revealing revenues of $6.2 million, an increase of 29% compared to $4.8 million in Q1 2022.

CARA

1 minute read

InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details

By Vuk Zdinjak

May 16, 6:40 AM

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequenti

INCR

2 minute read

Zoned Properties Stock Plummets On Q1 Revenue Decline Of 26% YoY

By Vuk Zdinjak

May 15, 9:53 AM

Zoned Properties, Inc. (OTCQB: ZDPY) revenues for the quarter ended March 31 2023, were $688,024, 2023, compared to revenues of $938,701 for the quarter ended March 31, 2022, representing a decrease of 26%.

ZDPY

2 minute read

Auxly Q1 Revenue Grows 6% YoY, Achieves First Quarter Of Positive Adjusted EBITDA

By Vuk Zdinjak

May 15, 9:33 AM

Auxly Cannabis Group Inc. (OTCQB: CBWTF) (TSX:XLY) released its financial results for the three months ended March 31, 2023, revealing net revenue of CA$24.0 million in Q1 2023, an increase of 6% compared to CA$22.6 million the same period

CBWTF

2 minute read

IM Cannabis Q1 Revenue Stagnates YoY, Here Is What You Need To Know

By Vuk Zdinjak

May 15, 9:08 AM

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of CA$13.2 million ($9.8 million) compared to CA$13 million in the first quarter of 2022, an increase of 1%.

CSE:IMCC

2 minute read

Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details

By Vuk Zdinjak

May 15, 8:46 AM

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) released financial results for the first quarter ended March 31, 2023, revealing research and development expenses were $7.1 million for the first quarter of 2023, including stock-based compensation of $400,000.

ZYNE